AdvisorShares Psychedelics ETF (PSIL) Holdings List $23.23 0.00 (0.00%) As of 07/2/2026 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock What stocks does PSIL hold? The AdvisorShares Psychedelics ETF (PSIL) top stock holdings include Definium Therapeutics, Compass Pathways, and Atai Beckley. The top 25 PSIL holdings ordered by weight make up 99.48% of the total fund. PSIL is an equity fund in the strategy category that invests in publicly traded companies and other investments, focused on theme strategies within the Global region. This page includes a complete PSIL stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure. Top 25 PSIL HoldingsRankCompanyCurrent PriceWeightShares Held1DFTXDefinium Therapeutics$44.1912.89%110,0762CMPSCompass Pathways$13.6211.58%326,0823ATAIAtai Beckley$5.199.59%800,5024RLMDRelmada Therapeutics$6.286.71%397,9515NRXPNRx Pharmaceuticals$3.875.70%612,0936Cybin Inc.N/A4.90%311,0717ALKSAlkermes$54.584.78%34,6038GHRSGH Research$27.014.75%71,7179NBIXNeurocrine Biosciences$174.264.30%10,01310ABBVAbbVie$260.88-0.1%4.23%6,653 Get the Latest News and Ratings for PSIL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AdvisorShares Psychedelics ETF and its competitors with MarketBeat's FREE daily newsletter. 11ANROAlto Neuroscience$24.780.0%4.18%63,19812JNJJohnson & Johnson$262.52-0.2%3.68%5,74813Blackrock Treasury Trust Instl 62N/A3.47%1,326,12814Bright Minds Biosciences Inc.N/A3.34%20,08415SUPNSupernus Pharmaceuticals$48.052.93%25,06316NEUPNeuphoria Therapeutics$3.382.61%229,31917STIMNeuronetics$1.412.24%673,49518Quantum BioPharma Ltd.N/A1.90%184,59419KTTAPasithea Therapeutics$0.551.20%850,05020SILOSilo Pharma$6.181.03%68,54721Optimi Health CorpN/A0.99%93,20422PBMPsyence Biomedical$3.040.79%110,80923VTGNVistaGen Therapeutics$0.250.64%397,72824Numinus Wellness Inc.N/A0.59%7,690,41725IXHLIncannex Healthcare$3.970.46%55,198 Related Companies and Tools Related Companies FDFF Portfolio NSI Portfolio FMET Portfolio GGME Portfolio SARK Portfolio LITP Portfolio ORBX Portfolio KNO Portfolio NBET Portfolio DRUP Portfolio This page (NYSEARCA:PSIL) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
